4-iodo-SAHA (CAS 1219807-87-0)
QUICK LINKS
4-iodo-SAHA, referred to as 4-iodo-N-hydroxyoctanediamide (IHOD), is a synthetic organic compound. This colorless solid exhibits solubility in various solvents, including water, ethanol, and dimethyl sulfoxide. 4-iodo-SAHA serves as a versatile reagent in chemical synthesis, a catalyst in biochemical reactions, and a ligand in protein-binding studies. In biochemical reactions, 4-iodo-SAHA assumes the role of a catalyst. It binds to the substrate, enabling its conversion into a product. The presence of 4-iodo-SAHA facilitates the reaction by interacting with the enzyme, enhancing its efficiency. Furthermore, 4-iodo-SAHA acts as a ligand in protein-binding studies, where it binds to the target protein, thereby assisting in the stabilization of its structure. To summarize, 4-iodo-SAHA, or 4-iodo-N-hydroxyoctanediamide (IHOD), is a synthetic organic compound extensively employed in scientific research. Its versatility as a reagent, catalyst, and ligand enables its utilization in various research applications.
4-iodo-SAHA (CAS 1219807-87-0) References
- Modified cap group suberoylanilide hydroxamic acid histone deacetylase inhibitor derivatives reveal improved selective antileukemic activity. | Salmi-Smail, C., et al. 2010. J Med Chem. 53: 3038-47. PMID: 20218673
- Histone deacetylase inhibitor screening identifies HC toxin as the most effective in intrahepatic cholangiocarcinoma cells. | Zhou, W., et al. 2016. Oncol Rep. 35: 2535-42. PMID: 26935789
- Image-based drug screen identifies HDAC inhibitors as novel Golgi disruptors synergizing with JQ1. | Gendarme, M., et al. 2017. Mol Biol Cell. 28: 3756-3772. PMID: 29074567
- Engineering Lineage Potency and Plasticity of Stem Cells using Epigenetic Molecules. | Dhaliwal, A., et al. 2018. Sci Rep. 8: 16289. PMID: 30389989
- Development of a Cell-Based High-Throughput Screening Assay to Identify Porcine Host Defense Peptide-Inducing Compounds. | Deng, Z., et al. 2018. J Immunol Res. 2018: 5492941. PMID: 30581875
- Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Suppresses Human Adenovirus Gene Expression and Replication. | Saha, B. and Parks, RJ. 2019. J Virol. 93: PMID: 30944181
- Epigenetic inhibitors target multiple stages of Plasmodium falciparum parasites. | Coetzee, N., et al. 2020. Sci Rep. 10: 2355. PMID: 32047203
- Screening of an Epigenetic Drug Library Identifies 4-((hydroxyamino)carbonyl)-N-(2-hydroxyethyl)-N-Phenyl-Benzeneacetamide that Reduces Melanin Synthesis by Inhibiting Tyrosinase Activity Independently of Epigenetic Mechanisms. | Song, H., et al. 2020. Int J Mol Sci. 21: PMID: 32605171
- Binding of inhibitors to active-site mutants of CD1, the enigmatic catalytic domain of histone deacetylase 6. | Osko, JD. and Christianson, DW. 2020. Acta Crystallogr F Struct Biol Commun. 76: 428-437. PMID: 32880591
- Identification of human adenovirus replication inhibitors from a library of small molecules targeting cellular epigenetic regulators. | Saha, B. and Parks, RJ. 2021. Virology. 555: 102-110. PMID: 33032802
- A novel chemical-combination screen in zebrafish identifies epigenetic small molecule candidates for the treatment of Duchenne muscular dystrophy. | Farr, GH., et al. 2020. Skelet Muscle. 10: 29. PMID: 33059738
- Selected Histone Deacetylase Inhibitors Reverse the Frataxin Transcriptional Defect in a Novel Friedreich's Ataxia Induced Pluripotent Stem Cell-Derived Neuronal Reporter System. | Schreiber, AM., et al. 2022. Front Neurosci. 16: 836476. PMID: 35281493
- Enhancement of Chromatin and Epigenetic Reprogramming in Porcine SCNT Embryos-Progresses and Perspectives. | Glanzner, WG., et al. 2022. Front Cell Dev Biol. 10: 940197. PMID: 35898400
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
4-iodo-SAHA, 50 mg | sc-364391 | 50 mg | $150.00 | |||
4-iodo-SAHA, 250 mg | sc-364391A | 250 mg | $676.00 |